Indication
Choriocarcinoma
3 clinical trials
4 products
8 drugs
Clinical trial
A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell TumorsStatus: Active (not recruiting), Estimated PCD: 2024-06-01
Drug
paclitaxelDrug
ifosfamideProduct
cisplatinProduct
Pegylated G-CSFDrug
FilgrastimDrug
carboplatinProduct
EtoposideClinical trial
A Prospective,Multicenter,Randomized Trial of Biweekly Single-dose Actinomycin-D Versus Multi-day Methotrexate Protocol for the Treatment of Low-risk Gestational Trophoblastic NeoplasiaStatus: Recruiting, Estimated PCD: 2024-12-01
Drug
DocetaxelDrug
mFOLFOX6Product
DactinomycinClinical trial
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare TumorsStatus: Active (not recruiting), Estimated PCD: 2026-05-01
Drug
LurbinectedinDrug
T-VEC